{"id":177,"date":"2011-11-15T01:59:48","date_gmt":"2011-11-14T16:59:48","guid":{"rendered":"http:\/\/preview-me.net\/m.ehime-u.ac.jp\/school\/radiology\/?post_type=results&p=177"},"modified":"2020-12-17T05:51:30","modified_gmt":"2020-12-16T20:51:30","slug":"2010%e5%b9%b4%e3%80%80%e3%81%9d%e3%81%ae2%ef%bc%88%e5%ad%a6%e4%bc%9a%e7%99%ba%e8%a1%a8%e3%80%81%e8%ac%9b%e6%bc%94%e3%80%81%e7%a0%94%e7%a9%b6%e5%8a%a9%e6%88%90%e3%80%81%e5%8f%97%e8%b3%9e%ef%bc%89","status":"publish","type":"results","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/results\/177\/","title":{"rendered":"2010\u5e74\u3000\u305d\u306e2\uff08\u5b66\u4f1a\u767a\u8868\u3001\u8b1b\u6f14\u3001\u7814\u7a76\u52a9\u6210\u3001\u53d7\u8cde\uff09"},"content":{"rendered":"

\u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09<\/a>
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/a>
\n\u25a0 \u8b1b\u6f14<\/a>
\n\u25a0 \u7814\u7a76\u52a9\u6210<\/a>
\n\u25a0 \u53d7\u8cde<\/a><\/p>\n

\u8ad6\u6587\u30fb\u8457\u66f8\u3001\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u306f2010\u5e74\u696d\u7e3e\u3000\u305d\u306e1<\/a>\u3092\u3054\u89a7\u4e0b\u3055\u3044\u3002<\/p>\n

—————————<\/p>\n

<\/a>\u25a0<\/span> \u5b66\u4f1a\u767a\u8868(\u56fd\u5185)<\/strong><\/p>\n

<\/a>\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a(\u5168\u56fd)<\/p>\n

1.\t\u5175\u982d\u670b\u5b50\uff0c\u83c5\u539f\u656c\u6587\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u5742\u5c71\u61b2\u53f2. \u795e\u7d4c\u7dda\u7dad\u816b\u306e\u5185\u90e8\u306b\u60aa\u6027\u672b\u68a2\u795e\u7d4c\u9798\u816b\u760d\uff08MPNST\uff09\u6210\u5206\u3092\u8a8d\u3081\u305f1\u4f8b. \u7b2c21\u56de\u9aa8\u8edf\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2010. 1\uff0c\u5927\u962a)
\n2.\t\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u4e95\u4e0a\u7950\u99ac\uff0c\u9577\u5c3e\u5c55\u5145\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u51a0\u52d5\u8108CT\u3068IB-IVUS\u306b\u3088\u308b\u30d7\u30e9\u30fc\u30af\u6027\u72b6\u8a55\u4fa1\u306e\u6bd4\u8f03\u691c\u8a0e\uff0c\u7b2c70\u56de\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.1\uff0c\u6771\u4eac\uff09
\n3.\t\u5c0f\u7530\u5c1a\u543e\uff0c\u4e09\u6728\u3000\u5747\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6751\u702c\u7814\u4e5f\uff0e\u8133\u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u30bd\u30d5\u30c8\u3092\u5229\u7528\u3057\u305f\u75c5\u5909-\u767d\u8cea\u30b3\u30f3\u30c8\u30e9\u30b9\u30c8\u306e\u691c\u8a0e\uff1a3T MRI\u30681.5T MRI\u306e\u6bd4\u8f03. \u7b2c39\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a\uff082010.02\uff0c\u6771\u4eac\uff09
\n4.\t\u5175\u982d\u670b\u5b50\uff0c\u6d25\u7530\u5b5d\u6cbb\uff0c\u6b66\u667a\u6075\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6e21\u9089\u5e38\u592a\uff0c\u7fbd\u7530\u91ce\u96c5\u82f1\uff0c\u9ad8\u7530\u6cf0\u6b21. \u30e9\u6c0f\u5cf6\u306e\u904e\u5f62\u6210\u3092\u6bcd\u5730\u3068\u3057\u3066\u767a\u751f\u3057\u305f\u81b5\u5185\u5206\u6ccc\u816b\u760d\u306e1\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6d88\u5316\u5668\u753b\u50cf\u7814\u7a76\u4f1a (2010. 2\uff0c\u6771\u4eac)
\n5.\t\u4e09\u6728\u3000\u5747\uff0c\u4f0a\u8cc0\u702c\u572d\u4e8c\uff0c\u677e\u539f\u4e00\u90ce\uff0c\u8c9e\u672c\u548c\u5f66. 3\u30c6\u30b9\u30e9\uff2d\uff32\uff21\u306b\u3088\u308b\u672a\u7834\u88c2\u8133\u52d5\u8108\u7624\u306e\u7d4c\u904e\u89b3\u5bdf. \u7b2c15\u56de\u4e09\u6b21\u5143\uff23\uff34\u30fb\uff2d\uff32\uff29\u7814\u7a76\u4f1a(2010.2.\u6771\u4eac)
\n6.\t\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u4e95\u4e0a\u7950\u99ac\uff0c\u9577\u5c3e\u5c55\u5145\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00\uff0cATP loaded Dual Energy CT in Assessment of Myocardial Ischemia ATP\uff0c\u7b2c74\u56de\u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a(2010.3\uff0c\u4eac\u90fd)
\n7.\t\u5c0f\u7530\u5c1a\u543e\uff0c\u4e09\u6728\u3000\u5747\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6751\u702c\u7814\u4e5f\uff0e\u8133\u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u30fc\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u30bd\u30d5\u30c8\u306b\u3088\u308b\u9020\u5f71\u52b9\u679c\u306e\u691c\u8a0e\uff1a3T MRI\u30681.5T MRI\u306e\u6bd4\u8f03. \u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082010.04\uff0c\u6a2a\u6d5c\uff09
\n8.\t\u5175\u982d\u670b\u5b50\uff0c\u6d25\u7530\u5b5d\u6cbb\uff0c\u5e73\u7530\u96c5\u662d\uff0c\u6b66\u667a\u6075\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u671b\u6708\u8f1d\u4e00. \u30ac\u30b9\u30c8\u30ed\u30b0\u30e9\u30d5\u30a3\u30f3CT\u306b\u3088\u308b\u8178\u763b\u306e\u8a55\u4fa1. \u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2010. 4\uff0c\u6a2a\u6d5c)
\n9.\t\u6b66\u667a\u6075\uff0c\u6d25\u7530\u5b5d\u6cbb\uff0c\u5175\u982d\u670b\u5b50\uff0c\u6751\u4e0a\u6b63\u54f2\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u897f\u5c71\u5149\uff0c\u4e0a\u7530\u5e78\u4ecb.\u3000Gd-EOB-DTPA\u306b\u3088\u308bdynamic\u64ae\u50cf\u3067\u306e\u81f3\u9069\u52d5\u8108\u76f8\u306e\u8a66\u307f. \u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u767a\u8868\u4f1a\uff082010.4\uff0c\u6a2a\u6d5c\uff09
\n10.\t\u6b66\u667a\u6075\uff0c\u6d25\u7530\u5b5d\u6cbb\uff0c\u5175\u982d\u670b\u5b50\uff0c\u6751\u4e0a\u6b63\u54f2\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6751\u7530\u7e41\u5229. EOB\u809d\u7d30\u80de\u76f8\uff0cCTA\uff0cCTAP\u3068\u306e\u6bd4\u8f03. \u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u767a\u8868\u4f1a\uff082010.4\uff0c\u6a2a\u6d5c\uff09
\n11.\t\u4e2d\u6751\u8aa0\u6cbb\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u5c71\u4e0b \u606d\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u68b6\u539f \u8aa0\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747. \u30002\u691c\u51fa\u5668\u578bSPECT\u88c5\u7f6e\u3092\u7528\u3044\u305fMicrosphere Split-dose\u6cd5\u306b\u3088\u308b\u5c40\u6240\u8133\u8840\u6d41\u91cf\u5b9a\u91cf. \u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2010. 4\uff0c\u6a2a\u6d5c)
\n12.\t\u8d8a\u667a\u8a89\u53f8\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u6ff1\u672c\u3000\u6cf0\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u83c5\u539f\u656c\u6587\uff0e\u524d\u7acb\u817a\u764c\u5c0f\u7dda\u6e90\u6c38\u4e45\u633f\u5165\u7642\u6cd5\u3000\u77ed\u671f\u6cbb\u7642\u6210\u7e3e\uff0e\u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082010.4\uff0c\u6a2a\u6d5c\uff09
\n13.\t\u6ff1\u672c\u3000\u6cf0\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u8d8a\u667a\u8a89\u53f8\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u57ce\u6238\u502b\u4e4b\uff0e\u80ba\u5b9a\u4f4d\u7167\u5c04\u3092\u65bd\u884c\u3057\u305fI\u671f\u539f\u767a\u6027\u80ba\u764c\u306b\u304a\u3051\u308b\u6cbb\u7642\u524dFDG\u96c6\u7a4d\u3068\u4e88\u5f8c\uff0e\u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082010.4\uff0c\u6a2a\u6d5c\uff09
\n14.\t\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u6ff1\u672c\u3000\u6cf0\uff0c\u8d8a\u667a\u8a89\u53f8\uff0e\u80ba\u306eSRT\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u80ba\u708e\u30fb\u7dda\u7dad\u75c7\u767a\u75c7\u4f8b\u306e\u5c40\u6240\u518d\u767a\u8a3a\u65ad\u3000FDG-PET\/CT\u306e\u96c6\u7a4d\u30d1\u30bf\u30fc\u30f3\u3092\u4e2d\u5fc3\u306b\uff0e\u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082010.4\uff0c\u6a2a\u6d5c\uff09
\n15.\t\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u4e95\u4e0a\u7950\u99ac\uff0c\u9577\u5c3e\u5c55\u5145\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00\uff0cATP loaded MSCT in Assessment of Myocardial Ischemia\uff0c\u65e5\u72ec\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\uff082010.5\uff0c\u6771\u4eac\uff09
\n16.\t\u83ca\u6c60\u6075\u4e00\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u4e09\u6728\u3000\u5747\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u9ad8\u91ce\u660c\u5e73\uff0c\u6e21\u908a\u82f1\u662d\uff0c\u5927\u4e0a\u53f2\u6717\uff0c\u6751\u702c\u7814\u4e5f. \u4e00\u5ea6\u306eMRI\u691c\u67fb\u3067\u4e8c\u3064\u306edynamic data\u3092\u53ce\u96c6\u3059\u308b\u8a66\u307f \u65e5\u672cMRA\u7814\u7a76\u4f1a (2010. 6\uff0c\u6771\u4eac)
\n17.\t\u5175\u982d\u670b\u5b50\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u6b66\u667a\u6075\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u6d25\u7530\u5b5d\u6cbb\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u67f3\u539f\u8c4a\uff0c\u5cf6\u672c\u61b2\u53f8\uff0c\u6a2a\u5c71\u96c5\u597d. \u6210\u4eba\u578bWilms\u816b\u760d\u306e1\u4f8b. \u7b2c24\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2010. 6\uff0c\u8efd\u4e95\u6ca2)
\n18.\t\u5409\u5ca1\u771f\u4e8c\uff0c\u8d77\u585a\u9999\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000Congenital Absence of the Portal Vein (CAPV)\u306e\u4e00\u4f8b\uff0e\u3000\u7b2c24\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(2010. 6\uff0c\u8efd\u4e95\u6ca2)
\n19.\t\u6b66\u667a\u6075\u3000\u6d25\u7530\u5b5d\u6cbb\u3000\u5175\u982d\u670b\u5b50\u3000\u6751\u4e0a\u6b63\u54f2\u3000\u7530\u4e2d\u5b8f\u660e\u3000\u671b\u6708\u8f1d\u4e00. \u7c98\u819c\u4e0b\u816b\u760d\u69d8\u5f62\u614b\u3092\u5448\u3057\u305fS\u72b6\u7d50\u8178\u7c98\u6db2\u764c\u306e1\u4f8b. \u7b2c24\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.6\uff0c\u8efd\u4e95\u6ca2\uff09
\n20.\t\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u4e09\u702c\u88d5\u5b50\uff0c\u91ce\u6cb3\u5b5d\u5145\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u5b50\u5bae\u9838\u90e8\u306b\u767a\u751f\u3057\u305f\u7a00\u306a\u7b4b\u816b\u306e1\u4f8b\uff0e\u7b2c24\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.6\u3000\u8efd\u4e95\u6ca2\uff09
\n21.\t\u83c5\u539f\u656c\u6587\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u7058\u91ce\u6210\u4eba\uff0c\u91ce\u6cb3\u5b5d\u5145\uff0c\u5927\u7530\u8015\u53f8\uff0c\u68da\u7530\u3000\u7a14\uff0c\u897f\u6751\u7406\u6075\u5b50\uff0e\u5e83\u7bc4\u306a\u5f8c\u8179\u819c\u6d78\u6f64\u3092\u304d\u305f\u3057\u305f\u80c6\u56a2\u764c\u306e1\u4f8b\uff0e\u7b2c24\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.6\u3000\u8efd\u4e95\u6ca2\uff09
\n22.\t\u9152\u4e95\u4f38\u4e5f\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u83c5\u539f\u656c\u6587\uff0c\u6a2a\u5c71\u3000\u9686\uff0c\u65e5\u6d66\u660c\u9053\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u4f4e\u60aa\u6027\u5ea6\u5b50\u5bae\u5185\u819c\u9593\u8cea\u8089\u816b\u306e1\u4f8b\uff0e\u7b2c24\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.6\u3000\u8efd\u4e95\u6ca2\uff09
\n23.\t\u4e95\u4e0a\u7950\u99ac\uff0c\u9577\u5c3e\u5145\u5c55\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6751\u702c\u7814\u4e5f.\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u306b\u304a\u3051\u308b\u5de6\u5ba4rotation\u3068\u7dda\u7dad\u5316\u306e\u95a2\u9023\uff1a3T\u30bf\u30ae\u30f3\u30b0\u3068LGE-MRI\u306b\u3088\u308b\u8a55\u4fa1. \u7b2c18\u56de\u65e5\u672cMRAngiography\u7814\u7a76\u4f1a\uff082010. 6\uff0c\u6771\u4eac\uff09
\n24.\t\u5c71\u4e0b\u3000\u606d\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537.\u3000Nasal tooth\u306e1\u4f8b. \u7b2c46\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a(2010.6.\u6803\u6728)
\n25.\t\u5c71\u4e0b\u3000\u606d\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u7530\u53e3\u5343\u8535\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747. \u5c0f\u5150\u30e1\u30c1\u30aa\u30cb\u30f3PET\/CT\u306e\u521d\u671f\u7d4c\u9a13. \u7b2c46\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a(2010.6.\u6803\u6728)
\n26.\t\u57ce\u6238\u502b\u4e4b\uff0c\u5009\u7530\u8056\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6cb3\u5185\u5bdb\u6cbb. \u4e0b\u5927\u9759\u8108\u304b\u3089\u767a\u751f\u3057\u305f\u5de8\u5927\u5fc3\u81d3\u7c98\u6db2\u816b\u306e\u4e00\u4f8b. \u7b2c71\u56de\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.7\uff0c\u718a\u672c\uff09
\n27.\t\u5c0f\u4e80\u96c5\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u5c71\u4e0b\u3000\u606d\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747. I-131\u5185\u7167\u5c04\u7642\u6cd5\u3067\u7570\u6240\u6027\u96c6\u7a4d\u3092\u5448\u3057\u305f1\u4f8b. \u7b2c113\u56de\u6838\u533b\u5b66\u75c7\u4f8b\u691c\u8a0e\u4f1a(2010.8.\u5927\u962a)
\n28.\t\u5bae\u5ddd\u6b63\u7537\uff0c\u5897\u539f\u3000\u6643\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u677e\u4e2d\u3000\u8c6a\uff0c\u5927\u6728\u5143\u660e\u7fa9\uff0c\u9234\u6728\u3000\u8aa0\uff0c\u671b\u6708\u8f1d\u4e00. \u30a2\u30f3\u30e2\u30cb\u30a2\uff0cFDG\u5fc3\u7b4bPET\/CT\u540c\u65e5\u6cd5\u304a\u3088\u3073FDG\u30d8\u30d1\u30ea\u30f3\u8ca0\u8377\u6cd5\u306e\u5b9f\u969b. PET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc2010 in \u5ca1\u5c71\uff1a\u81e8\u5e8a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 (2010. 8.\u5ca1\u5c71)
\n29.\t\u4e95\u4e0a\u3000\u6b66\uff0c\u83c5\u539f\u656c\u6587\uff0e\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e\u6cbb\u7642\u4e2d\u306b\u751f\u3058\u305f\u8179\u90e8\u816b\u7624\u306e1\u4f8b\uff0ePET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc\uff082010.8\u3000\u5ca1\u5c71\uff09
\n30.\t\u83c5\u539f\u656c\u6587\uff0c\u4e95\u4e0a\u3000\u6b66\uff0e\u5b50\u5bae\u9838\u764c\u6cbb\u7642\u5f8c\u306e\u7d4c\u904e\u89b3\u5bdf\u4e2d\u306b\u80ba\u91ce\u306b\u7570\u5e38\u9670\u5f71\u3092\u793a\u3057\u305f1\u4f8b\uff0ePET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc\uff082010.8\u3000\u5ca1\u5c71\uff09
\n31.\t\u5c71\u672c\u5c1a\u5e78\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u306b\u304a\u3051\u308b\u30db\u30fc\u30eb\u30dc\u30c7\u30a3\u30ab\u30a6\u30f3\u30bf\u306e\u5f79\u5272\u300d\u3000\u4f53\u5185\u6c5a\u67d3\u306e\u6709\u7121\u3068\u305d\u306e\u8a55\u4fa1\u306b\u95a2\u3059\u308b\u30db\u30fc\u30eb\u30dc\u30c7\u30a3\u30ab\u30a6\u30f3\u30bf\u306e\u5f79\u5272\u3002\u653e\u5c04\u7dda\u4e8b\u6545\u533b\u7642\u7814\u7a76\u4f1a\uff082010\uff0e9\uff0e\u5f18\u524d\uff09
\n32.\t\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u83c5\u539f\u656c\u6587\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u91ce\u6cb3\u5b5d\u5145\uff0c\u65e5\u6d66\u660c\u9053\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u975e\u7523\u8925\u6027\u5b50\u5bae\u5185\u53cd\u75c7\u3092\u6765\u3057\u305f\u5b50\u5bae\u5185\u819c\u764c\u306e1\u4f8b\uff0e JSAWI 11th Annual Symposium (2010.9\u3000\u6de1\u8def)
\n33.\t\u5009\u7530\u8056\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u9e7f\u7530\u6587\u662d\uff0c\u4eca\u5ddd\u5f18\uff0c\u5ca1\u5c71\u82f1\u6a39\uff0c\u6a9c\u57a3\u5be6\u7537\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00. \u30de\u30eb\u30c1\u30b9\u30e9\u30a4\u30b9CT\u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u30d0\u30a4\u30d1\u30b9\u8853\u524d\u8853\u5f8c\u306b\u304a\u3051\u308b\u5fc3\u7b4b\u8840\u6d41\u91cf\u306e\u5b9a\u91cf\u8a55\u4fa1. \u7b2c58\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff082010.9\uff0c\u6771\u4eac\uff09
\n34.\t\u57ce\u6238\u502b\u4e4b\uff0c\u5009\u7530\u8056\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u767d\u77f3\u6cf0\u5b8f\uff0c\u5c0f\u5cf6\u660e\u5f66\uff0c\u4e0a\u7530\u5e78\u4ecb. \u5f53\u9662\u306b\u304a\u3051\u308b3T MRI\uff0c32ch coil\u3092\u7528\u3044\u305f\u8ca0\u8377\u5fc3\u7b4b perfusion MRI\u306e\u7d4c\u9a13. \u7b2c38\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u5927\u4f1a\uff082010.9\uff0c\u6771\u4eac\uff09
\n35.\t\u7a32\u7530\u5b8f\u898f\uff0c\u4f0a\u85e4\u5609\u6d69\uff0c\u6817\u6797\u4f51\u591a\uff0c\u65b0\u5bb6\u5e79\u6574\uff0c\u6751\u5c71\u672b\u5229\uff0c\u4ed9\u6ce2\u8cb4\u654f\uff0c\u897f\u5d0e\u7d71. \u4f4d\u7f6e\u7cbe\u5ea6\u691c\u8a3c\u7528\u4eba\u982d\u30d5\u30a1\u30f3\u30c8\u30e0\u306e\u958b\u767a. \u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\u7b2c100\u56de\u5b66\u8853\u5927\u4f1a (2010.9\uff0c\u6771\u4eac)
\n36.\t\u5c0f\u7530\u5c1a\u543e\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u5e73\u585a\u7fa9\u5eb7\uff0c\u4e09\u6728\u3000\u5747\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6e21\u908a\u82f1\u662d\uff0eAcetazolamide\u8ca0\u8377\u3092\u4f75\u7528\u3057\u305fperfusion MRI\u306b\u3088\u308b\u8133\u5faa\u74b0\u4e88\u5099\u80fd\u306e\u8a55\u4fa1\uff1a\u8133\u8840\u6d41SPECT\u3068\u306e\u6bd4\u8f03. \u7b2c38\u56de\u65e5\u672c\u78c1\u5668\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff082010.9\uff0c\u7b51\u6ce2\uff09\uff0e
\n37.\t\u6b66\u667a\u6075\uff0c\u6d25\u7530\u5b5d\u6cbb\uff0c\u5175\u982d\u670b\u5b50\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u4e0a\u7530\u5e78\u4ecb.\u3000 Gd-EOB-DTPA\u306b\u3088\u308bdynamic\u64ae\u50cf\u3067\u306e\u81f3\u9069\u52d5\u8108\u76f8\u306e\u8a66\u307f. \u7b2c38\u56de\u65e5\u672c\u78c1\u5668\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff082010.9\uff0c\u7b51\u6ce2\uff09
\n38.\t\u8d77\u585a\u9999\u5b50\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000\u5b50\u5bae\u817a\u7b4b\u75c7\u3068\u306e\u9451\u5225\u304c\u56f0\u96e3\u3060\u3063\u305f\u5b50\u5bae\u5185\u819c\u9593\u8cea\u8089\u816b\u306e\u4e00\u4f8b\uff0e\u3000\u7b2c46\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(2010.9\uff0c\u6a2a\u6d5c)
\n39.\t\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u6fa4\u7530\u8302\u6a39\uff0c\u5c71\u4e0b\u7d20\u5f18\uff0c\u897f\u6751\u7406\u6075\u5b50\uff0e\u5de6\u4e3b\u6c17\u7ba1\u652f\u306b\u767a\u751f\u3057\u305f\u591a\u5f62\u817a\u816b\u306e1\u4f8b\uff0e\u7b2c46\u56de\u65e5\u672c\u306b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c\u7b2c24\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.9\u3000\u6a2a\u6d5c\uff09
\n40.\t\u83c5\u539f\u656c\u6587\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u5c71\u4e0b\u7d20\u5f18\uff0c\u897f\u6751\u7406\u6075\u5b50\uff0e\u80ba\u91ce\u672b\u68a2\u306e\u9650\u5c40\u6027\u3059\u308a\u30ac\u30e9\u30b9\u69d8\u9670\u5f71\u304b\u3089\u80ba\u9580\u5074\u3078\u3068\u9032\u5c55\u304c\u307f\u3089\u308c\u305f\u764c\u6027\u30ea\u30f3\u30d1\u7ba1\u75c7\u306e1\u4f8b\uff0e\u7b2c46\u56de\u65e5\u672c\u306b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c\u7b2c24\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082010.9\u3000\u6a2a\u6d5c\uff09
\n41.\t\u7530\u53e3\u3000\u5343\u85cf\uff0c\u85e4\u4e95\u3000\u5d07\uff0c\u897f\u5ddd\u3000\u6566\uff0c\u671b\u6708\u3000\u8f1d\u4e00\uff0e\u4e2d\u67a2\u795e\u7d4c\u7cfb\u539f\u767a\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u5358\u72ec\u3067\u306e\u4e88\u5f8c\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c48\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff082010\uff0e10\uff0c\u4eac\u90fd\uff09
\n42.\t\u5897\u539f\u3000\u6643\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u65b0\u85e4\u6cf0\u53f2\uff0c\u6c60\u7530\u826f\u4e00. Split-Dose\u6cd5\u3092\u57fa\u306b1\u70b9\u52d5\u8108\u30fb\u9759\u8108\u63a1\u8840\u306b\u5bfe\u5fdc\u3057\u305f\u5c40\u6240\u8133\u8840\u6d41\u5b9a\u91cf\u6cd5\u306e\u57fa\u790e\u691c\u8a0e. \u7b2c38\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a( 2010.10.\u4ed9\u53f0)
\n44.\t\u6e05\u6c34\u8f1d\u5f66\uff0c\u8d77\u585a\u9999\u5b50\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000\u7279\u767a\u6027\u981a\u690e\u786c\u819c\u5916\u8840\u816b\u306e\u4e00\u4f8b\uff0e\u3000\u7b2c39\u56de\u65ad\u5c64\u6620\u50cf\u7814\u7a76\u4f1a\uff082010.11\uff0c\u57fc\u7389\uff09
\n45.\t\u5bae\u5ddd\u6b63\u7537\uff0c\u77f3\u4e38\u826f\u5f18\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u4e80\u96c5\u5e83. \u4e0d\u660e\u71b1\u306e\u539f\u56e0\u78ba\u5b9a\u306b\u304a\u3051\u308bFDG PET\/CT \u306e\u6709\u7528\u6027. \u7b2c50\u56de \u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2010.11.\u5927\u5bae)
\n46.\t\u4e2d\u6751\u8aa0\u6cbb\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u4e0b\u3000\u606d\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747. 2\u691c\u51fa\u5668\u578b\u30ac\u30f3\u30de\u30ab\u30e1\u30e9\u3067\u306eSplit-dose\u6cd5\u3092\u57fa\u306b\u3057\u305f1\u70b9\u52d5\u8108\u63a1\u8840\uff0c\u9759\u8108\u63a1\u8840\u306b\u3088\u308b\u5c40\u6240\u8133\u8840\u6d41\u5b9a\u91cf\u6cd5\u306e\u6709\u7528\u6027. \u7b2c50\u56de \u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2010.11.\u5927\u5bae)
\n47.\t\u77f3\u4e38\u826f\u5e83\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537. \u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u306b\u304a\u3051\u308bFDG-PET\/CT\u306e\u6709\u7528\u6027. \u7b2c50\u56de \u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2010.11.\u5927\u5bae)
\n48.\t\u68ee\u672c\u88d5\u7d00\uff0c\u5897\u539f\u3000\u6643\uff0c\u5cf0\u96ea\u6d69\u7d9a\uff0c\u5ca1\u7530\u3000\u5065\uff0c\u65b0\u85e4\u6cf0\u53f2\uff0c\u6c60\u7530\u826f\u4e00\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb. 2\u691c\u51fa\u5668\u578b\u30ac\u30f3\u30de\u30ab\u30e1\u30e9\u3092\u7528\u3044\u305f\u8133\u8840\u6d41\u5b9a\u91cfSPECT(123I\u2010IMP split dose\u6cd5)\u306e\u8a66\u307f. \u7b2c30\u56de\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a(2010.11.\u5927\u5bae)
\n49.\t\u4e95\u4e0a\u3000\u6b66\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u83c5\u539f\u656c\u6587\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u68b6\u539f\u3000\u8aa0\uff0e\u8179\u81e5\u4f4d\u64ae\u50cf\u3092\u8ffd\u52a0\u3057\u3066\uff0c\u6c88\u6bbf\u3059\u308b\u764c\u7d30\u80de\u3078\u306eFDG\u96c6\u7a4d\u3092\u78ba\u8a8d\u3057\u305f\u764c\u6027\u80f8\u6c34\u306e\u75c7\u4f8b\uff0e\u7b2c50\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff082010.11\u3000\u3055\u3044\u305f\u307e\uff09
\n50.\t\u677e\u672c\u7f8e\u6075\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u83c5\u539f\u656c\u6587\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u68b6\u539f\u3000\u8aa0\uff0eUptake\u6642\u9593\u306e\u9055\u3044\u306b\u3088\u308b\u809d\u81d3\u90e8FDG-PETCT\u691c\u67fb\u306e\u753b\u50cf\u518d\u69cb\u6210\u6761\u4ef6\u6700\u9069\u5316\uff0e\u7b2c50\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff082010.11\u3000\u3055\u3044\u305f\u307e\uff09
\n51.\t\u83c5\u539f\u656c\u6587\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u68b6\u539f\u3000\u8aa0\uff0e\u80ba\u764c\u306e\u4f53\u5e79\u90e8\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u80ba\u7dda\u7dad\u75c7\u3068\u518d\u767a\u306e\u9451\u5225\u306b\u304a\u3051\u308bFDG-PET\/CT\u306e\u5f79\u5272\uff0e\u7b2c50\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff082010.11\u3000\u3055\u3044\u305f\u307e\uff09<\/p>\n

<\/a>\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/p>\n

\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/p>\n

1.\t\u5ddd\u53e3\u76f4\u4eba\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u4e0b\u3000\u606d\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u7530\u4e2d\u5b8f\u660e. \u5341\u4e8c\u6307\u8178\u9759\u8108\u7624\u306b\u5bfe\u3057\u3066BRTO\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u7b2c5\u56de\u611b\u5a9bIVR\u7814\u7a76\u4f1a(2010.2.\u677e\u5c71)
\n2.\t\u8d77\u585a\u9999\u5b50\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000\u5973\u6027\u9aa8\u76e4\u5185\u816b\u7624\u306e\u4e00\u4f8b.\u3000\u7b2c11\u56de\u611b\u5a9b\u9aa8\u76e4\u5185\u81d3\u5668\u753b\u50cf\u8a3a\u65ad\u7814\u7a76\u4f1a\uff082010.2\uff0c\u677e\u5c71\uff09
\n3.\t\u5c0f\u4e80\u96c5\u5e83\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u68b6\u539f\u8aa0\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u4e0b \u606d\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747. GIST\u306ePET\/CT(\u624b\u8853\u4f8b).\u3000\u7b2c4\u56de\u56db\u56fdPET\u52c9\u5f37\u4f1a(2010.3\uff0c\u677e\u5c71)
\n4.\t\u8d77\u585a\u9999\u5b50\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000\u4e0b\u8179\u90e8\u816b\u7624\u306e\u4e00\u4f8b\u3000\u7b2c25\u56de\u9053\u5f8c\u8179\u90e8\u753b\u50cf\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff082010.4\uff0c\u677e\u5c71\uff09
\n5.\t\u57ce\u6238\u502b\u4e4b. \uff13T MRI\uff0c32\u30c1\u30e3\u30f3\u30cd\u30eb\u30b3\u30a4\u30eb\u3092\u7528\u3044\u305fcardiac MRI\u306e\u521d\u671f\u7d4c\u9a13. \u7b2c21\u56de\u3057\u307e\u306a\u307f\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff082010.5\uff0c\u611b\u5a9b\uff09
\n6.\t\u57ce\u6238\u502b\u4e4b. \u5f53\u9662\u3067\u306e\uff13T MRI\uff0c32\u30c1\u30e3\u30f3\u30cd\u30eb\u30b3\u30a4\u30eb\u3092\u7528\u3044\u305fwhole heart coronary MRA\u306e\u521d\u671f\u7d4c\u9a13. \u7b2c6\u56de\u305b\u3068\u3046\u3061\u5fc3\u81d3MR\u52c9\u5f37\u4f1a(2010.4\uff0c\u611b\u5a9b)
\n7.\t\u7a32\u7530\u5b8f\u898f\uff0c\u4f0a\u85e4\u5609\u6d69\uff0c\u6817\u6797\u4f51\u591a\uff0c\u65b0\u5bb6\u5e79\u6574\uff0c\u6751\u5c71\u672b\u5229\uff0c\u4ed9\u6ce2\u8cb4\u654f\uff0c\u4ed9\u6ce2\u82b3\u6a39\uff0c\u771f\u934b\u4fca\u6cbb\uff0c\u897f\u5d0e\u7d71. \u4f4d\u7f6e\u7cbe\u5ea6\u691c\u8a3c\u7528\u4eba\u982d\u30d5\u30a1\u30f3\u30c8\u30e0\u306e\u958b\u767a. \u7b2c56\u56de\u4e2d\u56fd\u30fb\u56db\u56fd\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a (2010.6\uff0c\u4eca\u6cbb)
\n8.\t\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u6ff1\u672c\u3000\u6cf0\uff0c\u8d8a\u667a\u8a89\u53f8\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9752\u91ce\u7965\u53f8\uff0e\u4e0a\u54bd\u982d\u764c\u306e\u6cbb\u7642\u6210\u7e3e\uff0e\u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.6\uff0c\u4eca\u6cbb\uff09
\n9.\t\u9752\u91ce\u7965\u53f8\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u8d8a\u667a\u8a89\u53f8\uff0c\u6ff1\u672c\u3000\u6cf0\uff0c\u7247\u5ca1\u6b63\u660e\uff0e\u8178\u9aa8\u52d5\u8108\u5c3f\u7ba1\u763b\u306b\u5bfe\u3057\u30b9\u30c6\u30f3\u30c8\u30b0\u30e9\u30d5\u30c8\u3092\u7528\u3044\u3066\u6cbb\u7642\u3057\u305f\uff11\u4f8b\uff0e\u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.6\uff0c\u4eca\u6cbb\uff09
\n10.\t\u68b6\u539f\u3000\u8aa0\uff0c\u83c5\u539f\u656c\u6587\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u8d8a\u667a\u8a89\u53f8\uff0c\u6ff1\u672c\u3000\u6cf0\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u65e5\u6d66\u660c\u9053\uff0c\u5bfa\u672c\u5178\u5f18\uff0eFemale adnexal tumor of probable Wolffian origin\u306e1\u4f8b\uff0e\u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.6\uff0c\u4eca\u6cbb\uff09
\n11.\t\u4e95\u4e0a\u3000\u6b66\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u5409\u7530\u3000\u529f\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u30bc\u30f4\u30a1\u30ea\u30f3\u306e\u521d\u671f\u4f7f\u7528\u7d4c\u9a13\uff0e\u7b2c45\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.6\uff0c\u4eca\u6cbb\uff09
\n12.\t\u7a32\u6708\u5343\u5c0b\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u5c71\u4e0b \u606d\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747. \u5175\u982d\u670b\u5b50\uff0c\u671b\u6708\u8f1d\u4e00.\u3000\u526f\u814e\u9ed2\u8272\u817a\u816b\u306e\u753b\u50cf\u6240\u898b. \u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a (2010. 6\uff0c\u4eca\u6cbb)
\n13.\t\u5ddd\u53e3\u76f4\u4eba\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u4e0b\u3000\u606d\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747.\u3000\u5f8c\u8179\u819c\u816b\u7624\u3092\u4f34\u3063\u305fLAM\u306e1\u4f8b. \u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2010. 6\uff0c\u4eca\u6cbb)
\n14.\t\u5c0f\u4e80\u96c5\u5e83\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u7a32\u6708\u5343\u5c0b \uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u4e0b\u3000\u606d\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u4e09\u6728\u3000\u5747. \u3000\u8853\u524dGIST\u75c7\u4f8b\u306b\u304a\u3051\u308bPET\/CT\u306b\u3088\u308b\u4e88\u5f8c\u4e88\u6e2c\u306e\u691c\u8a0e. \u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2010. 6\uff0c\u4eca\u6cbb)
\n15.\t\u5e73\u585a\u7fa9\u5eb7\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u4ed6\uff0e\u900f\u6790\u30b7\u30e3\u30f3\u30c8PTA\u306b\u304a\u3051\u308b\u30ab\u30c3\u30c6\u30a3\u30f3\u30b0\u30d0\u30eb\u30f3\u30ab\u30c6\u30fc\u30c6\u30eb\u306e\u4f7f\u7528\u7d4c\u9a13\uff0e\u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2010. 6\uff0c\u4eca\u6cbb)
\n16.\t\u8d77\u585a\u9999\u5b50\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000\u5f53\u9662\u3067\u624b\u8853\u3092\u65bd\u884c\u3055\u308c\u7d44\u7e54\u5b66\u7684\u78ba\u5b9a\u304c\u5f97\u3089\u308c\u305f\u8033\u4e0b\u817a\u816b\u760d\uff1a\u9023\u7d9a22\u75c7\u4f8b\u306e\u753b\u50cf\u6240\u898b\u306e\u691c\u8a0e\uff0e\u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.6\uff0c\u4eca\u6cbb\uff09
\n17.\t\u8d77\u585a\u9999\u5b50\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000\u60aa\u6027\u4e0a\u76ae\u6027\u30fb\u9593\u8449\u6027\u6df7\u5408\u816b\u760d\u4e09\u75c7\u4f8b\u3068\u5b50\u5bae\u5185\u819c\u764c\u4e8c\u75c7\u4f8b\u306e\u6bd4\u8f03\u691c\u8a0e\uff0e\u3000\u7b2c114\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.6\uff0c\u4eca\u6cbb\uff09
\n18.\t\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u6ff1\u672c\u3000\u6cf0\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u8d8a\u667a\u8a89\u53f8\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u83c5\u539f\u656c\u6587\uff0c\u7247\u5ca1\u6b63\u660e\uff0e\u80ba\u816b\u760d\u306b\u5bfe\u3059\u308bSRT\u524d\u5f8c\u306ePET-CT\u306b\u304a\u3051\u308bFDG\u96c6\u7a4d\u306b\u3064\u3044\u3066\uff0e\u7b2c45\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.6\uff0c\u4eca\u6cbb\uff09
\n19.\t\u7530\u4e2d\u5b8f\u660e\uff0c\u5175\u982d\u670b\u5b50\uff0c\u6d25\u7530\u5b5d\u6cbb\uff0c\u5e73\u7530\u96c5\u662d\uff0c\u671b\u6708\u8f1d\u4e00. \u4e0a\u8178\u9593\u819c\u52d5\u8108\u72ed\u7a84\u75c7\u306b\u5bfe\u3057\u30b9\u30c6\u30f3\u30c8\u7559\u7f6e\u8853\u3092\u65bd\u884c\u3057\u305f1\u4f8b. \u7b2c24\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.9\uff0c\u5ca1\u5c71\uff09
\n20.\t\u77f3\u4e38\u826f\u5e83\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u7530\u4e2d\u5b8f\u660e.\u3000 Ehlers-Danlos syndrome \u2163\u578b\u306b\u5408\u4f75\u3057\u305f\u591a\u767a\u5185\u81d3\u52d5\u8108\u7624\u306b\u5bfe\u3057\u52d5\u8108\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f1\u4f8b.\u3000\u7b2c24\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a (2010.9.\u5ca1\u5c71)
\n21.\t\u5ddd\u53e3\u76f4\u4eba\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u5e73\u7530\u96c5\u662d\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u671b\u6708\u8f1d\u4e00. \u5341\u4e8c\u6307\u8178\u9759\u8108\u7624\u306b\u5bfe\u3057\u3066BRTO\u3092\u65bd\u884c\u3057\u305f2\u4f8b. \u7b2c24\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a (2010.9.\u5ca1\u5c71)
\n22.\t\u8d77\u585a\u9999\u5b50\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u8179\u90e8\u816b\u7624\u306e\u4e00\u4f8b\uff0e\u3000\u7b2c26\u56de\u9053\u5f8c\u8179\u90e8\u753b\u50cf\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff082010.10\uff0c\u677e\u5c71\uff09
\n23.\t\u57ce\u6238\u502b\u4e4b\uff0c\u5009\u7530\u8056\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6771\u91ce\u535a\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u767d\u77f3\u6cf0\u5b8f\uff0c\u5c0f\u5cf6\u660e\u5f66\uff0c\u4e0a\u7530\u5e78\u4ecb. \u5f53\u9662\u306b\u304a\u3051\u308b\u8ca0\u8377\u5fc3\u7b4bperfusion MRI\u306e\u7d4c\u9a13. \u7b2c7\u56de\u305b\u3068\u3046\u3061\u5fc3\u81d3MR\u52c9\u5f37\u4f1a(2010.11\uff0c\u611b\u5a9b)
\n24.\t\u4e95\u624b\u9999\u5948\uff0e\u8d64\u82bd\u7403\u308d\u3046\u3092\u5408\u4f75\u3057\u305fMulticentric Castleman\u2019s disease\u306e\u4e00\u4f8b\uff0e\u7b2c17\u56de\u4e2d\u56fd\u56db\u56fd\u80f8\u90e8\u753b\u50cf\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9(2010.11\uff0c\u9999\u5ddd)
\n25.\t\u5ddd\u53e3\u76f4\u4eba\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u4e80\u96c5\u5e83\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u4e0b\u3000\u606d\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747.\u3000\u6c17\u7ba1\u652f\u5185\u816b\u760d\u306e1\u4f8b. \u7b2c115\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.12\uff0c\u4e0b\u95a2\uff09
\n26.\t\u5c0f\u4e80\u96c5\u5e83\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u7a32\u6708\u5343\u5c0b \uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u4e0b\u3000\u606d\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e09\u6728\u3000\u5747. \u5e73\u5ca1\u3000\u6df3\uff0c\u9053\u582f\u6d69\u4e8c\u90ce\uff0c\u53e4\u8c37\u656c\u4e09\uff0c\u524d\u7530\u667a\u6cbb.\u3000Intravascular lymphoma\u306e2\u4f8b. \u7b2c115\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.12\uff0c\u4e0b\u95a2\uff09
\n27.\t\u68b6\u539f\u3000\u8aa0\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u9752\u91ce\u7965\u53f8\uff0c\u7058\u91ce\u6210\u4eba\uff0c\u897f\u6751\u7406\u6075\u5b50\uff0c\u68da\u7530\u3000\u7a14\uff0ePTPE\u5f8c\u306b\u8179\u58c1\u64ad\u7a2e\u518d\u767a\u3057\u305fHCC\u306e1\u4f8b\uff0e\u7b2c115\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.12\uff0c\u4e0b\u95a2\uff09
\n28.\t\u4e95\u4e0a\u3000\u6b66\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u7be0\u539f\u79c0\u4e00\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u897f\u6751\u7406\u6075\u5b50\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u304c\u3093\u8a3a\u7642\u62e0\u70b9\u75c5\u9662\u306b\u304a\u3051\u308bCT\u30ac\u30a4\u30c9\u4e0b\u9aa8\u751f\u691c\u306e\u73fe\u6cc1\uff0e\u7b2c115\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.12\uff0c\u4e0b\u95a2\uff09
\n29.\t\u4e0a\u6d25\u5b5d\u592a\u90ce\uff0c\u6ff1\u672c\u3000\u6cf0\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u7be0\u539f\u79c0\u4e00\uff0c\u8d8a\u667a\u8a89\u53f8\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u4e95\u4e0a\u3000\u6b66\uff0c\u83c5\u539f\u656c\u6587\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u9752\u5100\u5065\u4e8c\u90ce\uff0c\u5927\u4f4f\u7701\u4e09\uff0e\u4e73\u623f\u5207\u9664\u5f8c\u306e\u8853\u5f8c\u7167\u5c04\u306e\u9069\u5fdc\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c115\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.12\uff0c\u4e0b\u95a2\uff09
\n30.\t\u8d77\u585a\u9999\u5b50\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0e\u3000GIST5\u75c7\u4f8b\u306e\u691c\u8a0e\uff0e\u3000\u7b2c115\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.12\uff0c\u4e0b\u95a2\uff09
\n31.\t\u5ffd\u90a3\u8302\uff0c\u5409\u5ca1\u771f\u4e8c\uff0c\u8d77\u585a\u9999\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229\uff0eMRI jelly\u6cd5\u3092\u7528\u3044\u305f\u5973\u6027\u9aa8\u76e4\u5185\u6d88\u5316\u7ba1\u7652\u7740\u306e\u8a55\u4fa1\uff0d\u624b\u8853\u6240\u898b\u3068\u306e\u5bfe\u6bd4\u3092\u884c\u3063\u305f15\u75c7\u4f8b\u306eprospective study\uff0e\u7b2c115\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082010.12\uff0c\u4e0b\u95a2\uff09<\/p>\n

<\/a>\u25a0<\/span> \u8b1b\u6f14<\/strong><\/p>\n

1.\t\u6700\u4e0a\u3000\u535a, \u83c5\u539f\u793c\u5b50\uff0c\u4f50\u4e45\u9593\u97ff\u5b50, \u4e95\u4e0a\u88d5\u7f8e, \u524d\u7530\u6075\u7406\u5b50\uff0c\u7389\u5ca1\u7531\u4f73\u91cc\uff0c \u6c5f\u91cc\u53e3\u7f8e\u6c5f, \u5929\u91ce\u5922\u7f8e\uff0c\u5c0f\u91ce\u6c60\u88d5\u7f8e\u5b50, \u4f50\u4f2f\u3048\u307f, \u6804\u3000\u6d69\u53f8\uff0c\u5ddd\u4e0a\u58fd\u662d, \u5c0f\u816b\u7624\u6027\u75c5\u5909\u3092\u5448\u3057\u305f\u30de\u30f3\u30e2\u30b0\u30e9\u30d5\u30a3\u691c\u8a3a\u767a\u898b\u4e73\u304c\u3093\u306e\u753b\u50cf\u7684\u7279\u5fb4\u306e\u691c\u8a0e. \u7b2c20\u56de\u65e5\u672c\u4e73\u764c\u691c\u8a3a\u5b66\u4f1a (2010. 11, \u798f\u5ca1)
\n2.\t\u4e09\u6728\u3000\u5747: Stroke\u8a3a\u65ad\u306b\u5fc5\u9808MRI\u306e\u57fa\u672c. \u7b2c6\u56de\u611b\u5a9bStroke\u30bb\u30df\u30ca\u30fc:\u6559\u80b2\u8b1b\u6f14(2010.2,\u611b\u5a9b)
\n3.\t\u4e09\u6728\u3000\u5747: \u8001\u5e74\u671f\u8133\u795e\u7d4c\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad\uff1a\u8aad\u5f71\u306e\u30b3\u30c4\u3068\u843d\u3068\u3057\u7a74. \u7b2c23\u56de\u8001\u5e74\u8133\u795e\u7d4c\u5916\u79d1\u5b66\u4f1a\uff1a\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc(2010.3,\u611b\u5a9b)
\n4.\t\u5c71\u672c\u5c1a\u5e78\u3001\u6a4b\u53e3\u5c1a\u5e78. \u5cf6\u6839\u770c\u306e\u4ed5\u7d44\u307f\u3092\u7406\u89e3\u3059\u308b\uff0d\uff14\u3064\u306e\u30b1\u30fc\u30b9\u5bfe\u5fdc. \u5cf6\u6839\u770c\u300c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u521d\u7d1a\u8b1b\u5ea7\u300d\uff082010\uff0e6\uff0e\u51fa\u96f2\uff09
\n5.\t\u5c71\u672c\u5c1a\u5e78. \u653e\u5c04\u7dda\u3068\u306f\uff0d\u711a\u304d\u706b\uff08\u88ab\u3070\u304f\uff09\u3068\u30da\u30f3\u30ad(\u6c5a\u67d3)\uff0d. \u611b\u5a9b\u770c\u300c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u521d\u7d1a\u8b1b\u5ea7\u300d\uff082010\uff0e\uff17\uff0e\u677e\u5c71\uff09
\n6.\t\u5c71\u672c\u5c1a\u5e78. \u653e\u5c04\u7dda\u3068\u306f\uff0d\u711a\u304d\u706b\uff08\u88ab\u3070\u304f\uff09\u3068\u30da\u30f3\u30ad(\u6c5a\u67d3)\uff0d. \u5bae\u57ce\u770c\u300c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u521d\u7d1a\u8b1b\u5ea7\u300d\uff082010\uff0e\uff17\uff0e\u4ed9\u53f0\uff09
\n7.\t\u5c71\u672c\u5c1a\u5e78\uff0e\u4e09\u5927\u75be\u75c5\uff0b\u8a8d\u77e5\u75c7\u306e\u8a3a\u65ad\u304b\u3089\u5207\u3089\u305a\u306b\u6cbb\u3059\u764c\u6cbb\u7642\u307e\u3067\uff0e\u539f\u5b50\u529b\u30fb\u653e\u5c04\u7dda\u306b\u95a2\u3059\u308b\u6559\u80b2\u8077\u54e1\u30bb\u30df\u30ca\uff0d(\u5fdc\u7528\u30b3\u30fc\u30b9)\uff082010\uff0e\uff18\uff0e\u5e83\u5cf6\uff09
\n8.\t\u5c71\u672c\u5c1a\u5e78. \u9664\u67d3\u5b9f\u7fd2\uff0d\u6c5a\u67d3\u3092\u4f34\u3063\u305f\u5916\u50b7\u60a3\u8005\u306e\u53d6\u308a\u6271\u3044\uff0d. \u5cf6\u6839\u770c\u300c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u57fa\u790e\u8b1b\u5ea7\u2160\u300d\uff082010\uff0e8\uff0e\u677e\u6c5f\uff09
\n9.\t\u5c71\u672c\u5c1a\u5e78\u3001\u5927\u576a\u91cc\u7e54. \u9664\u67d3\u5b9f\u7fd2\uff0d\u6c5a\u67d3\u3092\u4f34\u3063\u305f\u5916\u50b7\u60a3\u8005\u306e\u53d6\u308a\u6271\u3044\uff0d. \u611b\u5a9b\u770c\u300c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u57fa\u790e\u8b1b\u5ea7\u2160\u300d\uff082010\uff0e9\uff0e\u677e\u5c71\uff09
\n10.\t\u5c71\u672c\u5c1a\u5e78. \u5b9f\u7fd2\u30fb\u691c\u8a3c\u201c\u8a3a\u7642\u4e2d\u306b\u6c5a\u67d3\u304c\u898b\u3064\u304b\u3063\u305f\u3002\u3055\u3041\u3001\u3069\u3046\u3059\u308b\uff1f\u201d\uff0e\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u5c02\u9580\u8b1b\u5ea7\u2161\uff082010\uff0e9\uff0e\u7acb\u5ddd\uff09
\n11.\t\u5c71\u672c\u5c1a\u5e78. \u9664\u67d3\u5b9f\u7fd2\uff0d\u6c5a\u67d3\u3092\u4f34\u3063\u305f\u5916\u50b7\u60a3\u8005\u306e\u53d6\u308a\u6271\u3044\uff0d. \u9e7f\u5150\u5cf6\u770c\u300c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u57fa\u790e\u8b1b\u5ea7\u2160\u300d\uff082010\uff0e10\uff0e\u9e7f\u5150\u5cf6\uff09
\n12.\t\u5c71\u672c\u5c1a\u5e78\uff0e\u4e09\u5927\u75be\u75c5\uff0b\u8a8d\u77e5\u75c7\u306e\u8a3a\u65ad\u304b\u3089\u5207\u3089\u305a\u306b\u6cbb\u3059\u764c\u6cbb\u7642\u307e\u3067\uff0e\u539f\u5b50\u529b\u30fb\u653e\u5c04\u7dda\u306b\u95a2\u3059\u308b\u6559\u80b2\u8077\u54e1\u30bb\u30df\u30ca\uff0d(\u5fdc\u7528\u30b3\u30fc\u30b9)\uff082010\uff0e11\uff0e\u9759\u5ca1\uff09
\n13.\t\u6771\u91ce \u535a. \u653e\u5c04\u7dda\u79d1\u533b\u304c\u53d6\u308a\u7d44\u3080\u3079\u304d\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad. \u7b2c63\u56de\u9999\u5ddd\u753b\u50cf\u8a3a\u65ad\u8ac7\u8a71\u4f1a. \u5e73\u621022\u5e7411\u670819\u65e5. \u9ad8\u677e\u30c6\u30eb\u30b5.
\n14.\t\u6771\u91ce \u535a. CMR\u306e\u6b74\u53f2\u3068\u9032\u3080\u3079\u304d\u65b9\u5411. \u7b2c6\u56de\u5bae\u5d0e\u5fc3\u81d3\u6838\u533b\u5b66\u7814\u7a76\u4f1a. (2010.10, \u5bae\u5d0e)
\n15.\t\u6771\u91ce \u535a. \u5fc3\u81d3\u6838\u533b\u5b66\u7dcf\u8ad6. \u7b2c4\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u533a\u5225\u7814\u4fee\u4f1a. (2010.100,\u9999\u5ddd)
\n16.\t\u6771\u91ce \u535a. \u6838\u533b\u5b66\u304cCT\/MR\u306e\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u306a\u3059\u3079\u304d\u3053\u3068. \u7b2c33\u56de\u5357\u4e88\u5faa\u74b0\u5668\u753b\u50cf\u7814\u7a76\u4f1a. (2010.8,\u5b87\u548c\u5cf6)
\n17.\t\u6771\u91ce \u535a. \u7279\u5225\u8b1b\u6f14 \u6838\u533b\u5b66\u304cCT\/MR\u306e\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u306a\u3059\u3079\u304d\u3053\u3068. \u7b2c50\u56de\u6771\u6d77\u5faa\u74b0\u5668\u6838\u533b\u5b66\u7814\u7a76\u4f1a. (2010.7,\u611b\u77e5)
\n18.\t\u6771\u91ce \u535a. \u6838\u533b\u5b66\u691c\u67fb\u306e\u539f\u7406 – \u5185\u5206\u6ccc\u30b7\u30f3\u30c1\u3084FGD-PET\u306f\u4f55\u3092\u898b\u3066\u3044\u308b\u306e\u304b? (2010.7,\u611b\u5a9b)
\n19.\t\u6771\u91ce \u535a. \u6559\u80b2\u8b1b\u6f14 CT\/MR\u3092\u727d\u5f15\u3059\u308b\u5fc3\u81d3\u6838\u533b\u5b66. \u7b2c71\u56de\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a. (2010.7,\u718a\u672c)
\n20.\t\u6771\u91ce \u535a. \u5fc3\u81d3CT\/MR\u6642\u4ee3\u306e\u6838\u533b\u5b66\u306e\u4fa1\u5024. \u7b2c21\u56de\u706b\u306e\u56fdRI\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2010.2,\u718a\u672c)
\n21.\t\u6771\u91ce \u535a. \u5fc3\u81d3\u6838\u533b\u5b66\u30c7\u30fc\u30bf\u306e\u96fb\u5b50\u30ab\u30eb\u30c6\u3067\u306e\u5229\u7528. \u7b2c35\u56de \u30cb\u30e5\u30fc\u30bf\u30a6\u30f3\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2010.2,\u795e\u6238)
\n22.\t\u83ca\u6c60 \u6075\u4e00. \u6559\u80b2\u8b1b\u6f14\u3000\u4e2d\u67a2\u795e\u7d4c\u3000\u865a\u8840\u6027\u8133\u8840\u7ba1\u969c\u5bb3. \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a (2010. 9,\u6a2a\u6d5c)
\n23.\tKurata A. T How to perform CT myocardial perfusion and viability -basics and scanning protocol. Clinical experience with 256MDCT for cardiac CT -advantages and advances-. Imaging of acute and chronic myocardial infarction-. Myocardial perfusion and viability assessment by CT. How to perform CT myocardial perfusion and viability -basics and scanning protocol. The 7th CT Coronary Angiography Teaching Course. (2010.7, Sydney)
\n24.\tKurata A. Clinical experience with 256MDCT for cardiac CT -advantages and advances-. Imaging of acute and chronic myocardial infarction-. Myocardial perfusion and viability assessment by CT. The 7th CT Coronary Angiography Teaching Course. (2010.8, Singapore)
\n25.\t\u5009\u7530\u3000\u8056. TP \u8ca0\u8377dynamic volume myocardial perfusion CT \u306e\u53ef\u80fd\u6027. \u7b2c4\u56deSCCT\u7814\u7a76\u4f1a (2010.9, \u6771\u4eac)
\n26.\t\u5009\u7530\u3000\u8056. \u6559\u80b2\u30bb\u30df\u30ca\u30fc1\uff1a\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff08\u5fc3\u81d3\uff09. \u7b2c115 \u56de \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a (2010. 12, \u4e0b\u95a2)
\n27.\t\u4ed9\u6ce2\u8cb4\u654f. \u5f53\u9662\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u3064\u3044\u3066. \u7b2c10\u56de\u4eca\u6cbb\u5730\u57df\u304c\u3093\u8a3a\u7642\u30d5\u30a9\u30fc\u30e9\u30e0(2010.7, \u4eca\u6cbb)
\n28.\t\u4ed9\u6ce2\u8cb4\u654f. \u4e73\u304c\u3093\u306e\u6cbb\u7642\u306b\u3064\u3044\u3066[2](\u653e\u5c04\u7dda\u6cbb\u7642). \u5730\u57df\u304c\u3093\u8a3a\u7642\u9023\u643a\u62e0\u70b9\u75c5\u9662\u5e02\u6c11\u516c\u958b\u8b1b\u5ea72010 (2010.8, \u4eca\u6cbb)
\n29.\t\u4ed9\u6ce2\u8cb4\u654f. \u5f53\u9662\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u3064\u3044\u3066. \u7b2c17\u56de\u533b\u7642\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2010.10, \u4eca\u6cbb)
\n30.\t\u57ce\u6238\u8f1d\u4ec1. \u5fc3\u81d3CT\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8840\u6d41\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3001SOTAC\uff082010.4,\u677e\u5c71\uff09
\n31.\t\u57ce\u6238\u8f1d\u4ec1. \u300c\u65e5\u5e38\u8a3a\u65ad\u306b\u304a\u3051\u308bDual Energy \u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u73fe\u72b6\u3068\u5c55\u671b\u300d\u2212DE\u306f\u65b0\u305f\u306a\u753b\u50cf\u8a3a\u65ad\u4f53\u7cfb\u306b\u6210\u308a\u5f97\u308b\u304b\u2212\u3001\u7b2c69\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff082010.4,\u6a2a\u6d5c\uff09
\n32.\t\u57ce\u6238\u8f1d\u4ec1. \u30de\u30eb\u30c1\u30e2\u30c0\u30ea\u30c6\u30a3\u3092\u99c6\u4f7f\u3057\u305f\u865a\u8840\u5fc3\u306e\u7d71\u5408\u8a55\u4fa1\u3001\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u30e9\u30a6\u30f3\u30c9\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff082010.6,\u6771\u4eac\uff09
\n33.\t\u57ce\u6238\u8f1d\u4ec1. MSCT\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8a55\u4fa1\uff5eDual Energy Imaging\u306e\u53ef\u80fd\u6027\uff5e. The 2nd Definition Symposium (2020. 7,\u6771\u4eac)
\n34.\t\u57ce\u6238\u8f1d\u4ec1. Cardiac CT\u306e\u65b0\u305f\u306a\u5c55\u671b\u301c\u5fc3\u7b4b\u8840\u6d41\u8a55\u4fa1\u306e\u53ef\u80fd\u6027\u301c\u3001\u7b2c46\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u671f\u81e8\u5e8a\u5927\u4f1a\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc(2010.9,\u6a2a\u6d5c\uff09<\/p>\n

<\/a>\u25a0<\/span> \u7814\u7a76\u52a9\u6210<\/strong><\/p>\n

\u8a72\u5f53\u306a\u3057<\/p>\n

<\/a>\u25a0<\/span> \u53d7\u8cde<\/strong><\/p>\n

1.\tRSNA 2010 award Winners: Certificate of Merit.
\nNakajima N, Sugawara Y, Takahashi T, Hamamoto Y, Ochi T, Kataoka M, Uwatsu K, Aono S, Sakai S, Inoue T. Role of FDG-PET\/CT in differentiating tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic body radiotherapy (SBRT) for lung cancer.<\/p>\n","protected":false},"template":"","class_list":["post-177","results","type-results","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/results\/177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/results"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/types\/results"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/media?parent=177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}